BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10359822)

  • 1. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.
    Auernhammer CJ; Bousquet C; Melmed S
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6964-9. PubMed ID: 10359822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
    Bousquet C; Melmed S
    J Biol Chem; 1999 Apr; 274(16):10723-30. PubMed ID: 10196143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
    Abbud RA; Kelleher R; Melmed S
    Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
    Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
    Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of a functional promoter of the human SOCS-3 gene.
    He B; You L; Uematsu K; Matsangou M; Xu Z; He M; McCormick F; Jablons DM
    Biochem Biophys Res Commun; 2003 Feb; 301(2):386-91. PubMed ID: 12565872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
    EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS proteins: modulators of neuroimmunoendocrine functions. Impact on corticotroph LIF signaling.
    Auernhammer CJ; Bousquet C; Chesnokova V; Melmed S
    Ann N Y Acad Sci; 2000; 917():658-64. PubMed ID: 11268394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V; Kariagina A; Melmed S
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SOCS-3 promoter responses to interferon gamma.
    Gatto L; Berlato C; Poli V; Tininini S; Kinjyo I; Yoshimura A; Cassatella MA; Bazzoni F
    J Biol Chem; 2004 Apr; 279(14):13746-54. PubMed ID: 14742442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization.
    Paul C; Seiliez I; Thissen JP; Le Cam A
    Eur J Biochem; 2000 Oct; 267(19):5849-57. PubMed ID: 10998044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.